South Korea’s Daewoong Pharmaceutical has signed a $25-million contract with Ibn Cina Drug Stores to supply six products to Jordan and Iraq.
According to the Korea Herald, the local partner will distribute:
• Ursa, for liver function improvement;
• Orlostar, for high blood pressure and hyperlipidemia;
• Easyef for diabetic foot ulcer;
• Daewoong pitavastatin calcium tab, for hyperlipidemia;
• antibiotic Gomcephin; and,
• Vitamin supplement Roman C powder.
The company entered the Middle Eastern market by launching growth hormone booster filler Caretropin in Iran in 2015 and is seeking to extend its market reach in the region.
Korea Herald
6 July
